Our Expertise

Our substantial expertise in molecular and stem cell biology, nanotechnology, in vivo imaging and preclinical drug development allows Theramir to successfully execute its R&D program and realize its aims - to lead the way in the development of first-in-class cancer therapeutics in the emerging field of targeted microRNA delivery and to position the company at the forefront of the emerging microRNA-based clinical diagnostics field.